Randomised open label clinical trial of the immune response to hepatitis B vaccination [hepatitis B vaccine recombinant] in HIV-infected persons.

Trial Profile

Randomised open label clinical trial of the immune response to hepatitis B vaccination [hepatitis B vaccine recombinant] in HIV-infected persons.

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2011

At a glance

  • Drugs Hepatitis B vaccine recombinant (Primary)
  • Indications Hepatitis B
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 Feb 2011 Primary endpoint 'Antibody-levels' has not been met
    • 25 Jan 2011 Results published in the Journal of Infectious Diseases.
    • 01 Jun 2010 Actual end date (Feb 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top